2 unknown, 1 active not recruiting, 1 completed, 1 not yet recruiting. 5 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Unknown 2, Active not recruiting 1, Completed 1, Not yet recruiting 1 |
| Phase 2 | 2 | Not yet recruiting 1, Unknown 1 |
Follow Nephrocalcinosis: new trials by email Literature Review of Nephrocalcinosis trials Research Report on Nephrocalcinosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The GranStone Trial empagliflozin (Jardiance) 25 mg, Losartan 100 mg - Paraffinoma, Granuloma, Foreign-Body | Phase 2 / Phase 3 | Not yet recruiting | Martin Blomberg Jensen | 100 | 2026-09-01 | 2026-09-18 |
| Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1 Encaleret, Standard of Care - Autosomal Dominant Hypocalcemia (ADH) | Phase 3 | Active not recruiting | Calcilytix Therapeutics, Inc., a BridgeBio company | 67 | 2023-01-06 | 2026-07-29 |
| ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study ACTHAR Gel (adrenocorticotropic hormone) - Sarcoidosis, Hypercalcemia Due to Sarcoidosis | Phase 2 / Phase 3 | Unknown | Albany Medical College | 10 | 2015-02-01 | 2015-01-26 |
| Study to Assess the Efficacy and Safety of Oral Potassium Citrate on the Prevention of Nephrocalcinosis in Extreme Premature Potassium Citrate, Placebo - Nephrocalcinosis | Phase 3 | Unknown | Juan A. Arnaiz | 74 | 2013-01-01 | 2012-12-27 |
| Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm Infants Alkaline citrate - Nephrocalcinosis | Phase 3 | Completed | University of Cologne | 80 | 2005-11-01 | 2012-07-03 |
Nephrolithiasis (3) · Hypercalcemia (2) · Hypercalciuria (2) · Calcium Metabolism Disorders (1) · Glomerulonephritis (1) · Granuloma, Foreign-Body (1) · Hypercalciuric Hypocalcemia, Familial (1) · Hypocalcemia (1) · Hypoparathyroidism (1) · Metabolic Diseases (1) · Muscular Diseases (1) · Musculoskeletal Abnormalities (1) · Musculoskeletal Diseases (1) · Nephritis, Interstitial (1)
Calcinosis (5) · Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Kidney Diseases (5) · Male Urogenital Diseases (5) · Nutritional and Metabolic Diseases (5) · Urogenital Diseases (5) · Urologic Diseases (5) · Calcium Metabolism Disorders (4) · Metabolic Diseases (4) · Pathological Conditions, Signs and Symptoms (3) · Urolithiasis (3) · Water-Electrolyte Imbalance (3) · Pathologic Processes (2) · Signs and Symptoms (2)
Adrenocorticotropic Hormone (1) · Losartan (1) · Potassium Citrate (1) · Sodium Chloride (1) · Standard of Care (1) · empagliflozin (1)
Albany Medical College (1) · Calcilytix Therapeutics, Inc., a BridgeBio company (1) · Juan A. Arnaiz (1) · Martin Blomberg Jensen (1) · University of Cologne (1)
Denmark (2) · United States (2) · Australia (1) · Canada (1) · Czechia (1) · France (1) · Germany (1) · Italy (1) · Japan (1) · Netherlands (1) · Spain (1) · United Kingdom (1)
Bernd Hoppe, Prof. Dr. (1) · Francisco Botet Mussons, MD (1) · Marc A Judson, MD (1) · Martin B Jensen, Professor (1)